AMP doubles its hypothetical investments in its current Picks to Click

AMP Biotech Analysts announced today, that it is matching its initial hypothetical investments as detailed below at today's closing prices, for its biopharma model portfolio. We are not certain what affect today's election will have on these stocks and biotech stocks in general. However, we find the current prices attractive for these companies and have room in our hypothetical model portfolio for post-election investments. See our web site for detailed analysis of the near-term drivers for these companies.*

FGEN - $25,000

NKTR - $25,000

ALKS - $25,000

QURE - $20,000

OPTH - $20,000

CYTR - $10,000

*This blog posting has been prepared by AMP Biopharma Ventures (“ABV”). This document is for information and illustrative purposes only and does not purport to show actual trades or results. It is not, and should not be regarded as investment or legal advice or as a recommendation regarding any particular security or course of action. Investment opinions expressed herein are current opinions as of the date appearing in this material only and are subject to change without notice. Reasonable people may disagree about the opinions expressed herein. In the event any of the assumptions used herein do not prove to be true, results are likely to vary substantially. All investments entail risks. There is no guarantee that investment strategies will achieve the desired results under all market conditions and each investor should evaluate its ability to invest for a long term especially during periods of a market downturn. No representation is being made that any account, product, or strategy will or is likely to achieve profits, losses, or results similar to those discussed, if any. No part of this document may be reproduced in any manner, in whole or in part, without the prior written permission of ABV. This information is provided with the understanding that with respect to the material provided herein, that you will make your own independent decision with respect to any course of action in connection herewith and as to whether such course of action is appropriate or proper based on your own judgment, and that you are capable of understanding and assessing the merits of a course of action. ABV does not purport to and does not, in any fashion, provide tax, accounting, actuarial, recordkeeping, legal, broker/dealer or any related services. You may not rely on the statements contained herein. ABV shall not have any liability for any damages of any kind whatsoever relating to this material. You should consult your advisors with respect to these areas. By accepting this material, you acknowledge, understand and accept the foregoing.